Gang (Gary) Hao, Ph.D.
Vice President, CMC
Gary brings 17 years of experience in CMC development for various biotherapeutics ranging from antibodies, fusion proteins to lipid nanoparticles, viral vectors and RNAs. Prior to joining ClimbBio, Gary took the roles as VP of CMC at Vesigen Therapeutics and VP of Analytical and Formulation at Codiak BioSciences. During the course of his career, Gary worked as key contributor to launching of marketed products (BAVENCIO and BRIUMVI). Gary obtained his bachelor’s degree in biochemistry from Nankai University and his Ph.D. degree in pharmacology from Weill Medical of Cornell University.
Standing tall at the pinnacle, all surroundings look infinitesimal. - Du Fu, AD 736